Also trades as: ZIVOW (NASDAQ) · $vol 0M
ZIVO OTC
ZIVO Bioscience, Inc.
1W: +25.8%
1M: +5.1%
3M: -20.9%
YTD: -58.1%
1Y: -67.5%
3Y: -41.4%
5Y: -87.3%
$4.15
+0.61 (+17.17%)
Weekly Expected Move ±19.9%
$3
$3
$4
$5
$6
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$4M
+25.6% ▲
Capital Expenditures
$0
+0.0% ▲
Free Cash Flow
-$4M
+25.6% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$1M
+183.2% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$9M | -$9M | -$9M | -$8M | -$13M |
| Depreciation & Amort. | $0 | -$556M | -$774K | $440K | $98K |
| Stock-Based Comp. | $1M | $3M | $3M | $867K | $9M |
| Change in Working Capital | $3M | -$394K | -$355K | $1M | -$500K |
| Other Non-Cash Items | $3M | -$623K | $80K | -$610K | $0 |
| Operating Cash Flow | -$3M | -$7M | -$7M | -$6M | -$4M |
| — Investing Activities — | |||||
| Capital Expenditures | $0 | $0 | $0 | $0 | $0 |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $0 | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 | $0 |
| — Financing Activities — | |||||
| Net Debt Issuance | $251K | $0 | $0 | $0 | -$21K |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $2M | -$2M | $629K | $4M | $0 |
| Financing Cash Flow | $2M | $16M | -$629K | $4M | $6M |
| Net Change in Cash | -$208K | $9M | -$7M | -$2M | $1M |
| Cash End of Period | $138K | $9M | $2M | $274K | $2M |
| Free Cash Flow | -$3M | -$7M | -$7M | -$6M | -$4M |